Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
107 Cards in this Set
- Front
- Back
Components of Blood
|
Plasma=55%
Blood cells=45% |
|
Blood Cells
|
Erythrocytes, Leukocytes, Platelets
|
|
Plasma
|
Water, Electrolytes, Salts, Plasma Protein
|
|
Erythrocytes
|
RBCs that filled with hemoglobin, transport CO2
|
|
Leukocytes
|
Defense and immunity
|
|
Platelets
|
Initiate blood clotting
|
|
Hemostasis
|
Stops bleading, limits hemmorage: vascular spasm, platelet plug formation, clot formation
|
|
Platelet Plug Formation
|
Vessels are damaged and Platelet adhesion, platelet activation/release, aggregation: leads to stickiness/clot formation
|
|
How does PPF work
|
Prothrombinase, Thrombine, Fibrinogen, insoluable threads that form the clot
|
|
Fibronalysis
|
Disolving of unwanted clots once the vessel is repaired
|
|
Pathways of blood circulation
|
Systemic; Pulmonary; Corinary
|
|
Systemic Circulation
|
Carries Oxygen and nutrients to body tissues and removes wastes
|
|
Pulmonary
|
Carries deox blood to lungs, excretion of CO2, returns oxygenated blood to heart
|
|
Corinary
|
Sub-pathway of systemic; removes wastes
|
|
Chambers (four hollow) continuously filled with blood
|
R/L Atria: upper (recepticles for blood coming into heart from body)
R/L Ventricle: lower (push blood back into body) |
|
Which system supplies blood directly to the heart?
|
Coronary circulation
|
|
Walls of blood vessels
|
Tunica externa
Tunica media Tunica interna/intima |
|
Tunica externa
|
Fibrous connective tissue
|
|
Tunica media
|
Smooth muscle and elastic tissue
|
|
Tunica interna/intima
|
Endothelial Tissue
|
|
Arteries
|
Carry blood away from the heart; two types: muscular and elastic (expand, receive blood during systole, recoil during diastole)
|
|
Arterioles
|
Smallest type of arteries; branch into capillaries (thin walls/single cell layer!); allows O2, nutrients from blood to cells
|
|
Valves of the heart
|
Prevent backflow of blood
AV Valves Semilunar valves Open and close according to pressure changes in chambers |
|
Atrioventricular Valves
|
Separate atria and ventricles: tricuspid and mitral (R&L)
|
|
Semilunar Valves
|
Regulate outflow of ventricles
|
|
Cardiac cycle
|
Systole (contracts)
Diastole (relaxes) |
|
Layers of the Heart
|
Three layers: epicardium (outer, epithelial), myocardium (middle, striated muscle), endocardium (inner, smooth)
|
|
Main vessels of the heart
|
Aorta and coronary arteries
Superior/Inferior vena cava R&L pulmonary veins R&L pulmonary arteries |
|
Aorta and coronary arteries
|
Supply body and heart with oxygenated blood
|
|
Superior/inferior vena cava
|
Return deox blood to heart
|
|
Cycle of systemic circulation
|
Ox blood from lungs--> Pulmonary veins-->
Left Atrium--> Left Ventricle--> Aorta--> Arterial system--> Body's Tissues and organs |
|
Cycle of pulmonary circulation
|
Deoxygenated blood from vena cava-->right atrium--> right ventricle-->pulmonary arteries-->lungs-->blood unloads CO2, picks up O2--> Left atrium-->systemic circulation
|
|
Cycle of coronary circulation
|
O2 blood carried thru coronary arteries-->capillaries in heart tissue -->deox blood --> cardiac veins-->coronary sinus-- right atrium
|
|
Cardiac Cycle
|
Normally: 60-80 BPM
Ventricular systole: contraction Ventricular diasole: relaxation |
|
Cardiac Output
|
CO=HRxSV
Amount of blood ejected from the L or R ventricle each minute (mL/minute) |
|
Nervous System Control of BP
|
Parasympathetic Stim (decreases HR & impulses)
Sympathetic Stimulation (increases HR & impulses |
|
Cardia Muscle Cell Contraction
|
- Deplorization/ Repolarization triggers change in e` potential of cell membrane
-This releases a Ca Ion, which shortens cadiac cells -Muscle contracts |
|
Blood Flow Variables
|
Blood Pressure: Force exerted by flood on vessel walls
BP = CO x TPR |
|
TPR
|
Total Peripheral Resistance: Sum of all opposition to blood flow from force of friction between blood and vessel walls
|
|
Hormonal Control of BP
|
Kidneys: nephrons filter blood and reabsorb H20
Renin-Angiotensin-aldosterone system (RAAS) regulates BP |
|
Malfunctions of RAAS
|
Affect both cardiac output and peripheral resistance
|
|
RAAS Flow...
|
Decreased arterial pressure-->Renin (kidney)-->Angiotensin I-->Angiotensin II-->Leads to: Increase in Na/H20 Retention; in vasoconstriction; in system arterial pressure
|
|
Other hormones involved in PB control
|
ADH and ANP:
Antidiuretic hormone and Atrial Natriuretic Peptide |
|
Aldosterone
|
Homrone that causes vasoconstriction and causes body to retain sodium and water, which means increased BP
|
|
HYPERTENSION
|
Inappropriately sustained elevation in BP
|
|
Optimal BP for adult is:
|
<120/80 mm Hg
|
|
JNC 7 Classification
|
Hypertension=BP>140/90
Prehypertension=BP between 120/80 and 139/89 Goal: to decrease elevated BP<140/90 |
|
Primary Hypertension
|
Over 95% of cases
Cause unknown |
|
Secondary Hypertension
|
Causes: Renal, Adrenal, Other (oral contraceptives, narrowing of the aorta, hyperthyroidism)
|
|
Possible causes of Primary Hypertension
|
Genetics; fetal environment; increased activity of vasoconstrictor systems; renal Na retention; Vascular Hypertrophy; decreased activity of vasodilating systems; insulin resistance
|
|
Other factors possibly causing Primary Hypertension
|
Obesity; alcohol intake; physical activity; smoking
|
|
True or False: prevalence of hypertension increases with age
|
TRUE
More common in Men up to age 50; equal in gender between 50 & 74; after 74 more common in women (estrogen protective effect) |
|
Hypertension is under___, under___, and poorly con___.
|
Underdiagnosed, undertreated, and poorly controlled.
|
|
NHANES Data Stats
|
Not aware: 31.1%
Not treated: 41.6% Not controlled: 46.9% (among treated patients) |
|
Hypertension Diagnosis:
|
-No symptoms until it's progressed to the point of damaging organs
-BP eval; Clinical eval; Lab evals |
|
BP Evaluations
|
-Baseline calculated by averaging cuff readins at 2 or more visits
-JNC7 recs f/u if initial pressure reading is found |
|
Ambulatory (out of office) readings (BP evals)
|
Verify white coat hypertensio; access antihypertensive treatments; improve compliance; reduce physician visits
|
|
Clinical Evaluations
|
-Medical History; Previous records; family; CV risk factors; signs/symptoms, concomitant medications
-Phyiscal exam: funduscopic; cardiac; arteries; phyiscal appearance |
|
Laboratory Evaluations
|
Urinalysis (renal status); Blood chem eval (blood cell count, K, creatinine, LDL, glucose, BUN)
Electrocardiogram (cardiac status LVH; provide baseline pre therapy) |
|
Consequences of Hypertension
|
1. Endothelial Damage
2. Organ Damage 3. Atherosclerotic Plaques |
|
Endothelial Damage
|
Hypertension damages endothelium of blood vessels: lining thickens; vessel narrows; flow impeded
|
|
Organ Damage
|
Eyes: hemorrhages, blurred, blindness
Heart: ventricular hypertrophy, atherosclerosis Kidneys: decreased blood supply, renal disease Brain: stroke, aneurysm rupture, TIA, embolus |
|
Stroke
|
Injury or death of brain tissue that causes loss of speech, vision, sensation, or ability to move a limb
|
|
TIA
|
Transient Ischemic Attack: a mini-stroke.
Brief cerebral vascular ischemia causing focal neurological signs/symptoms lasting less than 24 hours; precursor to stroke |
|
Atherosclerotic Plaques (clinical consequences of hypertension)
|
Atherosclerotic plaques develop in people with high lipid levels: changes in plaque occur and blood flow obstructed
|
|
Walls of arterials
|
Tunica intima, media, externa
|
|
Dyslipidemia (defined)
|
1. Pressence of abnormal levels of lipids, lipoproteins in blood
2. Elevated levels of VLDL, LDL, IDL, TGs 3. Low levels of HDL |
|
Chylomicrons
|
Chylomicrons: transport dietary TGs and C from small intestine to body tissues post meal
|
|
Blood Pressure equation
|
BP=COxPR
(Cardiac Output x Peripheral resistance) |
|
Medical definition for hypertension
|
High blood pressure
|
|
Types of Lipoproteins
|
Chylomicrons; VLDLs; LDLs; HDLs
|
|
VLDLs
|
VLDLs: tranport lipids from liver to fat tissue; converted to LDLs
|
|
LDLs
|
LDLs: Tranport Cholesterol from liver to body tissue; increase risk for atherosclerosis
|
|
HDLs
|
Tranport excess Cholesterol from body tissue to liver; reduce risk for atherosclerosis
|
|
Friedewald Formula
|
Formual used to calculate LDL-C when TG are <400mg/dL:
LDL=TC - HDL - (TG/5) |
|
Lipid Synthesis
|
Exogenous vs. Endogenous
|
|
Exogenous
|
Exogenous pathway: lipids obtained from diet
|
|
Endogenous
|
Endogenous pathway: lipids made by liver
|
|
Lipid sythesis (cont.)
|
Decrease: LDO receptors and uptake of LDL
Increase LDL in blood and risk of atherosclerosis |
|
Types of Lipid Disorders
|
Hyperlipidemia
Dyslipidemia (Dys/Hyperlipidemia and hypercholesterolemia used interchangably by Drs) |
|
Hyperlipidemia
|
Elevated levels of lipids, usually VLDL, LDL, IDL & TGs
|
|
Dyslipidemia
|
Elevated levels of bad lipids and low levels of HDL
|
|
Classifications of Dyslipidemia
|
Primary vs. secondary: based on cause of dyslipidemia
Fredrickson classification: based on patterns of lipid elevations Genotypic classifciation: based on genetic causes of primary dyslipidemias Clincial classification: based on which lipids are elevated/reduced |
|
Hypertrophy
|
Increased size of a part caused by an increase in the size of its cells
|
|
Primary dyslipidemia
|
Genetic/no ID'd cause
60-70% of LDL level is genetics Due to complex interaction of gens: age, gender, saturated fat diet, physical activity |
|
Secondary dyslipidemia
|
Known causes: Lifestyle; metabolid disorders; kidney; liver; hormonal; medications; pregnancy
|
|
Fredrickson classifcaiton
|
*Patients classified according to which lipids/lipoproteins are elevated
*I, IIa, IIb, III, IV, V *Treatment often based on lipid phenotype *Not based on HDL levels |
|
Genotypic Classification
|
*Classifies lipid disorders according to known genetic cause (primary only)
*Homozygous familial hypercholesterolemia (FH): 2 mutated LDL receptor alleles Heterozygous FH: having 1 mutated LDL receptor allele |
|
Clinical Classification
|
Relies on results of blood tests for lipids
Four main catagories: 1. elevated cholesterol/ hypercholesterolemia 2. elevated TGs/hypertriglyceridemia 3. elevated cholesterol and TGs /mixed dyslipidemia 4. Low HDL |
|
NCEP ATP III
|
*2001 published guidelines for classification of cho levels
*2004 addendum made to NCEP ATP III for those at very high risk |
|
NCEP ATP III Classificatoin of Lipid Levels
|
Optional LDL: <70 mg/dL
Optimal LDL: <100 Desirable TOTAL C: <200 Low HDL: <40 High HDL: >60 Normal TGs <150 |
|
Epidemiology of Dyslipidemia
|
105 million Americans have borderline high to high range of total cholesterol
|
|
Clinical consequences
|
Can lead to atherosclerosis, which lead to: Angina, MI, Stroke
|
|
Lipid Hypothesis
|
Evolved in last 50 years
Based on study data Central to CHD, lowering lipeds lowers risk of CHD |
|
Framingham Heart Study
|
*1948 in Framingham, MA
*5127 people 30-62 years old w/o diseases *Study to show CHD are related to high lipids/lipoproteins *CHD risk increases with increased total-C |
|
MRFIT
|
Multiple Risk Factor Intervention Trial
*Random, multicenter, 7-yr study *12,866 mid-age men w/ no CHD but w/ mutliple risk factors *1% reduction in total-C-->2% reduction in CHD risk |
|
Atherosclerosis
|
Buildup of fatty substances (plaque) on walls of arteries/reduces blood flow
May take decades for symptoms to show up |
|
Protective Factors
|
HDL-C: removes C from arterial walls, tranports to liver for exretion
Exercise: weight control, incrase levels of HDL, lower BP, reduce risk of heart attack Alcohol: moderate intake may protect against CHD & Athscl |
|
Initiation of Atherosclerosis
|
1. Chronic endothelial injury (from atherscl risk factors)
2. Accumulation of lipids at the site of the injury (prolif of muscle cells) 3. Oxidation/modification of LDL-C (inflammation response) 4. Formation and death of foam cells (fatty streaks) |
|
Progression of Atherosclerosis
|
*Fatty streaks progress to atheromas: lesion-->lumen; soft lipid core, hard fibrous cap
*Growth of plaque is outward/positive remodeling *Fibrous plaque grows/stable |
|
Stable Plaques
|
*Thick fibrous cap, low inflammation, low lipid content
*Outcome: stenosis-->occlusion *Symptoms: angina, claudication |
|
Unstable plaques
|
Thin fibrous cap; high inflammation; high lipid content; may lead to thrombosis
|
|
Complications of Atherosclerosis
|
1. Clots/Thrombi form around fissures in vessel walls
2. Fibrous cap can rupture; lipid core spilled into blood |
|
Types of Thrombosis
|
1. Mural: clot spreads along artery wall; doesn't occlude lumen
2. Occlusive: Clot fills lumen, obstructs blood flow; may cause MI |
|
Clinical Consequences
|
Heart: Ischemic heart disease: angina, acute MI, arrhythmias, CHF
Peripheral tissues/organs: PVD: claudication, gangrene, renal stenosis, ED Brain: ____ disease: stroke TIA |
|
Stroke
|
CVA: cerebrovascular accident
Occurs when O2 and nutrient flow to brain is interrupted b/c a blood vessel is blocked or burst Two types: Ischemic (blocked blood vessel) and Hemorrhagic (burst blood vessel) |
|
Stroke Epidemiology
|
*500,000/year in US experience 1st stroke
*200,000+/year exp 2nd stroke *3rd leading cause of deathin in US and devel countries *Leading cause of long-term disability *Risk factors include those for atherosclerosis |